Co-Authors
                            
                            
                                This is a "connection" page, showing publications co-authored by Aikaterini Thanou and Judith James.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.989
         
        
        
     
 
    
        
        - 
            Serologic markers of Epstein-Barr virus reactivation are associated with increased disease activity, inflammation, and interferon pathway activation in patients with systemic lupus erythematosus. J Transl Autoimmun. 2021; 4:100117.
            
            
                Score: 0.187
             
- 
            Adults with systemic lupus exhibit distinct molecular phenotypes in a cross-sectional study. EClinicalMedicine. 2020 Mar; 20:100291.
            
            
                Score: 0.169
             
- 
            Scoring systemic lupus erythematosus (SLE) disease activity with simple, rapid outcome measures. Lupus Sci Med. 2019; 6(1):e000365.
            
            
                Score: 0.167
             
- 
            Impact of heart rate variability, a marker for cardiac health, on lupus disease activity. Arthritis Res Ther. 2016 09 02; 18:197.
            
            
                Score: 0.133
             
- 
            How should lupus flares be measured? Deconstruction of the safety of estrogen in lupus erythematosus national assessment-systemic lupus erythematosus disease activity index flare index. Rheumatology (Oxford). 2014 Dec; 53(12):2175-81.
            
            
                Score: 0.112
             
- 
            Which outcome measures in SLE clinical trials best reflect medical judgment? Lupus Sci Med. 2014; 1(1):e000005.
            
            
                Score: 0.112
             
- 
            Lupus patient decisions about clinical trial participation: a qualitative evaluation of perceptions, facilitators and barriers. Lupus Sci Med. 2020; 7(1):e000360.
            
            
                Score: 0.042
             
- 
            The Biomarkers of Lupus Disease Study: A Bold Approach May Mitigate Interference of Background Immunosuppressants in Clinical Trials. Arthritis Rheumatol. 2017 06; 69(6):1257-1266.
            
            
                Score: 0.035
             
- 
            Development and validation of a simple lupus severity index using ACR criteria for classification of SLE. Lupus Sci Med. 2016; 3(1):e000136.
            
            
                Score: 0.032